The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(4-Methoxyphenyl)butanoyl)benzo[d]isothiazol-3(2H)-one ID: ALA3360056
PubChem CID: 118724033
Max Phase: Preclinical
Molecular Formula: C18H17NO3S
Molecular Weight: 327.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(CCCC(=O)n2sc3ccccc3c2=O)cc1
Standard InChI: InChI=1S/C18H17NO3S/c1-22-14-11-9-13(10-12-14)5-4-8-17(20)19-18(21)15-6-2-3-7-16(15)23-19/h2-3,6-7,9-12H,4-5,8H2,1H3
Standard InChI Key: YZQKWJFJWRAGSA-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
9.8197 -8.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8197 -9.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5273 -9.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2392 -9.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2392 -8.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5273 -7.9168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0205 -8.0729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5049 -8.7381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0205 -9.3993 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.3235 -8.7381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7306 -8.0288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7306 -9.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5491 -9.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9603 -10.1528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7817 -10.1528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1903 -10.8646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0116 -10.8646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4243 -10.1528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0116 -9.4410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1903 -9.4410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2428 -10.1528 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6500 -9.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2763 -7.2943 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 5 1 0
8 7 1 0
9 8 1 0
4 9 1 0
8 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
13 14 1 0
15 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
21 22 1 0
7 23 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 327.41Molecular Weight (Monoisotopic): 327.0929AlogP: 3.73#Rotatable Bonds: 5Polar Surface Area: 48.30Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.91CX LogD: 3.91Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.72Np Likeness Score: -0.66
References 1. Li Z, Pan Y, Zhong W, Zhu Y, Zhao Y, Li L, Liu W, Zhou H, Yang C.. (2014) Synthesis and evaluation of N-acyl-substituted 1,2-benzisothiazol-3-one derivatives as caspase-3 inhibitors., 22 (24): [PMID:25468037 ] [10.1016/j.bmc.2014.11.005 ]